As of June 2025, more than 1,100 devices have been granted breakthrough designation, with 160 authorized for use. ...
In his new role, Mr. AlMalki will be responsible for spearheading EMMA International’s growth strategy throughout ...
The US Food and Drug Administration (FDA) has finalized its guidance on the use of animal studies in the ...
AbbVie recently made a bold move into the emerging field of psychedelic-based psychiatry by acquiring Gilgamesh ...
The European life sciences sector is navigating a turbulent regulatory environment. Recent developments across the ...
On-body delivery systems (OBDS) are changing the way patients receive medications, offering convenience, improved ...
Some FDA approvals have sparked debate, drawing attention from the media, lawmakers, patient advocacy groups, and ...
Eli Lilly is gaining momentum in the obesity treatment landscape following compelling Phase 3 trial results for ...
The U.S. Food and Drug Administration (FDA) has released draft guidance to help sponsors design and assess ...
The rapid growth of cellular and gene therapy development has brought groundbreaking opportunities to patients, ...
Pulse oximeters are critical devices that estimate blood oxygen levels by shining red and infrared light through ...
The Prescription Drug User Fee Act (PDUFA) has reshaped how quickly new therapies reach patients since its ...